Natus Medical (Nasdaq:NTUS) announced today that ArchiMed’s investment firm completed its previously announced acquisition of the company. In April, the company announced that the MED Platform II fund of ArchiMed — an investment firm focused on the healthcare industry — would acquire Natus, a developer of medical devices for screening, diagnosing and treating disorders affecting […]
ArchiMed Group
Archimed Group to acquire Natus Medical for $1.2B
Natus Medical today announced that it entered a definitive agreement to be acquired by Archimed for a total equity value of $1.2 billion. Through the agreement, Natus shareholders will receive $33.50 in cash for each share of Natus common stock to represent a 29% premium to the stock’s close price on April 14. “The sale […]